(Q39481257)

12 September 2017

title

Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men. (English)

1 reference

12 September 2017

0 references

Maurice Anidjar

1

1 reference

12 September 2017

Eleonora Scarlata

2

1 reference

12 September 2017

Fabio L Cury

3

1 reference

12 September 2017

Joice Rocha

4

1 reference

12 September 2017

Lucie Hamel

5

1 reference

12 September 2017

Murilo Luz

6

1 reference

12 September 2017

Simone Chevalier

7

1 reference

12 September 2017

language of work or name

1 reference

31 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

72

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

752-761

1 reference

describes a project that uses

12 September 2017

DPC-1

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Emerging novel therapies in the treatment of castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

In vivo models of prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: Isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Development of a large animal model for lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Characterization of bone metastases from rapid autopsies of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21479

21 January 2018

Identifiers

DOI

10.1002/PROS.21479

1 reference

12 September 2017

1 reference